13 August 2020PatentsRory O'Neill

USPTO urges Fed Circuit to wait for SCOTUS on Arthrex

The US Patent and Trademark Office (USPTO) wants a federal appeals court to hold off on a dispute over Patent Trial and Appeal Board (PTAB) fees until the US Supreme Court has resolved Arthrex.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Patents

USPTO reveals post-Arthrex review process

30 June 2021 As a result of the recent Supreme Court decision in US v Arthrex, the US Patent and Trademark Office issued new interim procedures on Tuesday, June 29, that give the office’s director the authority to rehear final Patent Trial and Appeal Board rulings.

Patents

Brown Rudnick hires Greenberg Gross partner

20 August 2020 Brown Rudnick has strengthened its Orange County office with the addition of David Stein as a partner in the firm’s IP and commercial litigation practice group.

Patents

USPTO wants SCOTUS to halt Arthrex appeals

29 July 2020 The USPTO wants the country’s Supreme Court to delay dealing with a combined petition challenging almost 40 court judgments until a constitutional snag has been resolved.

UK-India trade deal is ‘missed opportunity’, say industry bodies

WATCH: Recent developments in design patent law

SEPs now searchable on WIPO’s global patent database

INTA 2025: San Diego to host largest post-COVID Annual Meeting

'Nothing can stand in the way of our work': Ukraine resumes IP system

Foley adds five-partner team from Perkins Coie and K&L Gates

WATCH: Finding a new balance in IP protection with trade secret protection

Optis v Apple: How the court calculated the royalty rate

USPTO urges Fed Circuit to wait for SCOTUS on Arthrex

More on this story

Editor's picks

Editor's picks

More articles